Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)

The Lancet Infectious Diseases
Marc BourlièreStanislas Pol

Abstract

Patients with cirrhosis resulting from chronic hepatitis C virus (HCV) infection are at risk of life-threatening complications, but consistently achieve lower sustained virological response (SVR) than patients without cirrhosis, especially if treatment has previously failed. We assessed the efficacy and safety of the NS5A inhibitor ledipasvir and the nucleotide polymerase inhibitor sofosbuvir, with and without ribavirin. In this multicentre, double-blind trial, between Oct 21, 2013, and Oct 30, 2014, we enrolled patients with HCV genotype 1 and compensated cirrhosis who had not achieved SVR after successive treatments with pegylated interferon and protease-inhibitor regimens at 20 sites in France. With a computer-generated randomisation sequence, patients were assigned in a 1:1 ratio to receive placebo matched in appearance to study drugs for 12 weeks followed by once daily combination fixed-dose tablets of 90 mg ledipasvir and 400 mg sofosbuvir plus weight-based ribavirin for 12 weeks, or ledipasvir-sofosbuvir plus placebo once daily for 24 weeks. The primary endpoint was SVR 12 weeks after the end of treatment (SVR12), for which 95% CIs were calculated with the Clopper-Pearson method. This study is registered with ClinicalTri...Continue Reading

References

Mar 3, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Savino BrunoPatrick Maisonneuve
Aug 18, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ira M JacobsonChristian Trépo
Jan 11, 2012·Liver International : Official Journal of the International Association for the Study of the Liver·Marc BourlièrePaul Castellani
Aug 3, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michael W FriedMaria Beumont-Mauviel
Jan 17, 2014·The New England Journal of Medicine·Mark S SulkowskiUNKNOWN AI444040 Study Group
Apr 15, 2014·The New England Journal of Medicine·Fred PoordadBarry Bernstein
Apr 15, 2014·The New England Journal of Medicine·Nezam AfdhalUNKNOWN ION-2 Investigators
Aug 15, 2014·JAMA : the Journal of the American Medical Association·Anita KohliShyam Kottilil
Sep 15, 2014·Journal of Hepatology·Stuart C GordonUNKNOWN HCV-TARGET study group

❮ Previous
Next ❯

Citations

Dec 2, 2015·Infectious Diseases·Martin LaggingUNKNOWN Swedish Consensus Group
Nov 26, 2015·Expert Review of Gastroenterology & Hepatology·Marc BourlièrePhilippe Halfon
Jun 6, 2015·Expert Opinion on Drug Safety·Yousef FazelZobair Younossi
Feb 24, 2016·Open Forum Infectious Diseases·Nik HowesBrian James Thomson
Mar 30, 2016·Mediators of Inflammation·Akihiro TamoriNorifumi Kawada
Dec 15, 2015·Journal of Hepatology·Martin-Walter WelkerChristoph Sarrazin
Feb 27, 2016·International Journal of Antimicrobial Agents·Alejandro Pérez-PitarchMatilde Merino-Sanjuán
Nov 2, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eleanor M WilsonShyam Kottilil
Aug 25, 2015·Journal of Hepatology·Maria ButiRafael Esteban
Mar 5, 2016·Expert Opinion on Pharmacotherapy·Laurent Alric, Delphine Bonnet
Aug 8, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Xavier FornsGregory Everson
Dec 26, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sammy SaabNezam H Afdhal
Nov 26, 2015·Gastroenterology Clinics of North America·Saleh Alqahtani, Mark Sulkowski
Apr 6, 2016·Clinical and Molecular Hepatology·UNKNOWN Korean Association for the Study of the Liver
May 28, 2015·Alimentary Pharmacology & Therapeutics·C Bunchorntavakul, K R Reddy
Aug 1, 2015·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Bandar Al-Judaibi
Aug 1, 2015·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Faisal M SanaiMohammed Y Alghamdi
Apr 22, 2015·Nature Reviews. Gastroenterology & Hepatology·Peter Ferenci
Apr 22, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Elise J SmoldersDavid M Burger
May 6, 2016·Expert Opinion on Pharmacotherapy·Laura Benítez-GutiérrezVicente Soriano
Mar 19, 2016·Transplant Infectious Disease : an Official Journal of the Transplantation Society·S CiesekM Sterneck
Jul 1, 2016·Current Infectious Disease Reports·Mark W HullJulio S G Montaner
Jul 22, 2016·Journal of Clinical Pharmacy and Therapeutics·V L FerreiraR Pontarolo
Jul 28, 2016·Alimentary Pharmacology & Therapeutics·A A ButtUNKNOWN ERCHIVES Study Team
Apr 21, 2016·Journal of Medical Virology·Lan S WangIra M Jacobson
Oct 30, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Elena KnopsSaleta Sierra
Nov 1, 2016·Expert Opinion on Drug Metabolism & Toxicology·Francisca Cuenca-LopezAntonio Rivero-Juárez
Jul 31, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Jordan J FeldJean-Michel Pawlotsky
Nov 18, 2016·Journal of Comparative Effectiveness Research·Emma GrayAisling O'Leary
Oct 8, 2016·Transplant International : Official Journal of the European Society for Organ Transplantation·Lionel RostaingNassim Kamar
Dec 13, 2016·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Brigitta GlobkeDennis Eurich

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.